26082716|t|Intranasal deferoxamine attenuates synapse loss via up-regulating the P38/HIF-1alpha pathway on the brain of APP/PS1 transgenic mice.
26082716|a|The widely recognized neuroprotective effect of iron chelators is contributed by their ability to prevent reactive oxygen species (ROS) generation via the Fenton reaction, which sequesters redox-active Fe. An additional neuroprotective mechanism of iron-chelating compounds is to regulate the transcriptional activator hypoxia-inducible factor 1alpha (HIF-1alpha). In the present study, we observed that intranasal administration of deferoxamine decreased beta-amyloid (Abeta) deposition and rescued synapse loss in the brain of Abeta precursor protein and presenilin-1 (APP/PS1) double transgenic mice. We found that deferoxamine (DFO) up-regulated HIF-1alpha mRNA expression and its protein level, and further induced the proteins that are encoded from HIF-1-adaptive genes, including transferrin receptor (TFR), divalent metal transporter 1 (DMT1), and brain-derived neurotrophic factor (BDNF). The effects of DFO on the induction and stabilization of HIF-1alpha were further confirmed in vitro. This was accompanied by a decrease of Fe in the CA3 region of the hippocampus. Western blotting studies revealed that DFO differentially enhanced the phosphorylation of mitogen-activated protein kinase (MAPK)/P38 kinase in vitro and in vivo. The results suggest that the DFO may up-regulate several HIF-1-dependent neuroprotective-adaptive genes in AD via activating P38/HIF-1alpha pathway, which may serve as important therapeutic targets to the disease. 
26082716	11	23	deferoxamine	Chemical	MESH:D003676
26082716	35	47	synapse loss	Disease	MESH:D016388
26082716	70	73	P38	Gene	26416
26082716	74	84	HIF-1alpha	Gene	15251
26082716	113	116	PS1	Gene	19164
26082716	128	132	mice	Species	10090
26082716	182	186	iron	Chemical	MESH:D007501
26082716	240	263	reactive oxygen species	Chemical	MESH:D017382
26082716	265	268	ROS	Chemical	MESH:D017382
26082716	336	338	Fe	Chemical	MESH:D007501
26082716	383	387	iron	Chemical	MESH:D007501
26082716	453	484	hypoxia-inducible factor 1alpha	Gene	15251
26082716	486	496	HIF-1alpha	Gene	15251
26082716	567	579	deferoxamine	Chemical	MESH:D003676
26082716	604	609	Abeta	Gene	11820
26082716	634	646	synapse loss	Disease	MESH:D016388
26082716	663	668	Abeta	Gene	11820
26082716	691	703	presenilin-1	Gene	19164
26082716	709	712	PS1	Gene	19164
26082716	732	736	mice	Species	10090
26082716	752	764	deferoxamine	Chemical	MESH:D003676
26082716	766	769	DFO	Chemical	MESH:D003676
26082716	784	794	HIF-1alpha	Gene	15251
26082716	921	941	transferrin receptor	Gene	22042
26082716	943	946	TFR	Gene	22042
26082716	949	977	divalent metal transporter 1	Gene	18174
26082716	979	983	DMT1	Gene	18174
26082716	990	1023	brain-derived neurotrophic factor	Gene	12064
26082716	1025	1029	BDNF	Gene	12064
26082716	1047	1050	DFO	Chemical	MESH:D003676
26082716	1089	1099	HIF-1alpha	Gene	15251
26082716	1171	1173	Fe	Chemical	MESH:D007501
26082716	1251	1254	DFO	Chemical	MESH:D003676
26082716	1404	1407	DFO	Chemical	MESH:D003676
26082716	1482	1484	AD	Disease	MESH:D000544
26082716	1500	1503	P38	Gene	26416
26082716	1504	1514	HIF-1alpha	Gene	15251
26082716	Positive_Correlation	MESH:D003676	26416
26082716	Negative_Correlation	MESH:D003676	11820
26082716	Negative_Correlation	MESH:D003676	MESH:D007501
26082716	Positive_Correlation	MESH:D003676	22042
26082716	Positive_Correlation	MESH:D003676	12064
26082716	Association	MESH:D000544	26416
26082716	Positive_Correlation	MESH:D003676	18174
26082716	Positive_Correlation	MESH:D003676	15251
26082716	Association	MESH:D007501	15251
26082716	Association	MESH:D000544	15251
26082716	Association	MESH:D003676	MESH:D000544
26082716	Association	MESH:D016388	15251
26082716	Association	MESH:D016388	19164
26082716	Association	15251	26416
26082716	Negative_Correlation	MESH:D003676	MESH:D016388
26082716	Association	MESH:D007501	MESH:D017382

